Watch PLSE. Know when insiders buy.
One email the day a filing lands. Free.
Work order
67
PASS · insiders 64, shorts 70
Insiders, 90 days
+$200K
net buying · 4 buys, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.9BP/E —DIV YIELD —FCF YIELD -1.57%REV TTM $1.2MNET INCOME −$80.1MNET CASH —52W 12.66 – 54.71NEXT EARNINGS Nov 5SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $434K | — | 37.1% | −$25.3M | −$24.7M | — | -0.36 | −$18.7M | $90K | −$18.8M | Aug 6 |
| Q1 2026 · Mar 31 | $401K | — | 7.7% | −$19.1M | −$18.6M | — | -0.27 | −$14.6M | $33K | −$14.6M | Aug 6 |
| Q4 2025 · Dec 31derived | $264K | — | 1.5% | −$18.3M | −$17.4M | — | -0.26 | −$14.8M | $105K | −$14.9M | Feb 19 |
| Q3 2025 · Sep 30 | $86K | — | -224.4% | −$20.4M | −$19.4M | — | -0.29 | −$13M | $62K | −$13.1M | Nov 5 |
| Q2 2025 · Jun 30 | $0 | — | — | −$20.3M | −$19.2M | — | -0.28 | −$12.8M | $103K | −$12.9M | Aug 6 |
| Q1 2025 · Mar 31 | $0 | — | — | −$18M | −$16.8M | — | -0.25 | −$13.5M | $45K | −$13.6M | Aug 6 |
| Q4 2024 · Dec 31derived | $0 | — | — | −$20.3M | −$19.4M | — | -0.32 | −$9.1M | $53K | −$9.2M | Feb 19 |
| Q3 2024 · Sep 30 | $0 | — | — | −$13.7M | −$12.7M | — | -0.21 | −$9M | $38K | −$9.1M | Nov 5 |
| Q2 2024 · Jun 30 | $0 | — | — | −$11.7M | −$11.4M | — | -0.20 | −$8.4M | $29K | −$8.4M | Aug 12 |
| Q1 2024 · Mar 31 | $0 | — | — | −$10.6M | −$10.1M | — | -0.18 | −$9.8M | $5K | −$9.8M | May 8 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$12.5M | −$11.9M | — | -0.21 | −$6.8M | $43K | −$6.8M | Mar 31 |
| Q3 2023 · Sep 30 | $0 | — | — | −$11.3M | −$10.6M | — | -0.19 | −$10.5M | $23K | −$10.5M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $350K | -54.0% | −$76.9M | −$72.8M | -20794.6% | -1.08 | −$54.1M | $315K | −$54.4M | — | — |
| FY2024 · to Dec 31 | $0 | — | −$56.3M | −$53.6M | — | -0.92 | −$36.3M | $125K | −$36.5M | — | — |
| FY2023 · to Dec 31 | $0 | — | −$43.6M | −$42.2M | — | -0.85 | −$33M | $121K | −$33.2M | — | — |
| FY2022 · to Dec 31 | $700K | -1606.3% | −$58.1M | −$58.5M | -8357.9% | -1.72 | −$47M | $401K | −$47.4M | — | — |
| FY2021 · to Dec 31 | $1.4M | -38.8% | −$63M | −$63.7M | -4489.4% | -2.28 | −$54.1M | $437K | −$54.5M | — | — |
| FY2020 · to Dec 31 | $0 | — | −$50M | −$49.9M | — | -2.14 | −$35.4M | $441K | −$35.8M | — | — |
Every number comes from PULSE BIOSCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.